Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06938412 · ClinicalTrials.gov registry record · NA

Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

A NA study of Cardiovascular Diseases and Atrial Fibrillation, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06938412 is a NA study of Cardiovascular Diseases and Atrial Fibrillation that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 120 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06938412, a NA study of Cardiovascular Diseases and Atrial Fibrillation, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and burden in clinical studies. However, lack of access to exercise programs has limited therapeutic adoption. The growth of technology-driven health care and diagnostics, recognized as an emerging priority by the American Heart Association, offers an opportunity for a pragmatic and patient-centered approach to meet this need. EASE-AF is a prospective, interventional study with a sequential run-in control to evaluate if a digital health-driven, patient-centered exercise intervention improves AF symptoms and burden. The research team will enroll 120 patients with symptomatic, paroxysmal AF. The main impact of this study will be the establishment of evidence for a novel, pragmatic paradigm for a patient-centered, digital technology-driven personalized exercise intervention for patients with AF.

Interventions

  • DEVICE Physical Activity Intervention Using FitBit Wearable Device

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-10
Est. Completion 2027-03-31
Phase NA

What the Registry Record Tells You About NCT06938412

The ClinicalTrials.gov registry entry for NCT06938412 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Physical Activity Intervention Using FitBit Wearable Device is the first listed.

NCT06938412 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06938412 about?

NCT06938412 is a clinical study titled "Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation". Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and burden in clinical studies. However, lack of access to exercise programs has limited therapeutic adop...

What is the current status of trial NCT06938412?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-10. Estimated completion is 2027-03-31.

What conditions does trial NCT06938412 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Atrial Fibrillation, Arrhythmias, Cardiac.

What interventions are being tested in trial NCT06938412?

The interventions under investigation include: Physical Activity Intervention Using FitBit Wearable Device (DEVICE).

Who is sponsoring clinical trial NCT06938412?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06938412 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.